Discover the #iDR26 Lightning Talks
Get ready for a fast‑paced session showcasing the innovation within the #REMEDi4ALL community. Six speakers from diverse backgrounds will take the stage to share stories designed to inform, inspire, and spark new collaborations.
🔗 https://loom.ly/9dw7qdk
💻 #REMEDi4ALL Funders Network Webinar: Working with Regulators: Pre-grant scientific advice
Funders & regulators discuss why pre‑grant regulatory scientific advice (PGRSA) matters for #DrugRepurposing, with real case studies + insights from IncreaseNET.
🔗 Materials: https://loom.ly/ZTiu4mQ
❄️ Season’s greetings from #REMEDi4ALL! We are grateful for your support in advancing drug repurposing and look forward to continued impact in the year ahead.
Prof. Irena Mlinarič Raščan of the University of Ljubljana, a REMEDi4ALL partner, was recently featured in DELO, Slovenia’s largest daily newspaper, in an in-depth article exploring the future of drug repurposing and her work with #REMEDi4ALL.
🔗 Read the article here: https://loom.ly/9kv7-MY
Prof. Irena Mlinarič Raščan, EATRIS Slovenia National Director, was recently featured in DELO, Slovenia’s largest daily newspaper, in an in-depth article exploring the future of drug repurposing and her work with #REMEDi4ALL.
🔗 Read the article here: https://loom.ly/_t-qKXk
🎤 As coordinator of #REMEDi4ALL, we were proud to see the project represented at the recent #IRDiRC General Assembly in Paris, where Gauthier Bouche (Anticancer Fund) spoke on EU #DrugRepurposing initiatives and patient impact in #RareDiseases.
👉 Find out more here: https://irdirc.org
🎤 #REMEDi4ALL takes the stage at the #iRDiRC General Assembly Meeting in Paris!
Gathier Bouche from The Anticancer Fund joined a session on EU drug repurposing initiatives, where he showcased how REMEDi4ALL is advancing the repurposing of medicines.
🔗 https://irdirc.org/
At the 2025 #REMEDi4ALL Hackathon near Montserrat, 14 early career researchers from 10 countries joined experts to tackle real-world #DrugRepurposing challenges in rare neurodevelopmental disorders.
Read the full event summary and discover who won here➡️https://loom.ly/N6tXCHs
This week, our representive #Nikola_Panajotovikj, is attending the 2025 #REMEDi4ALL Hackathon. He will present how #SafetyVista (safety-vista.com) can be used to explore postmarketing drug safety data and drug-target affinities.💊
👉 remedi4all.org/event/2025-r...
An EATRIS delegation is at #RExPO25 in Barcelona, sharing outcomes from the #REMEDi4ALL project we coordinate – from patient engagement and training to our new partnering portal and global collaborations in #DrugRepurposing.
It was a pleasure to organise and attend the 4th #REMEDi4ALL General Assembly meeting in Ljubljana last week! Two full days of learnings, networking, and planning for the future of drug repurposing. Huge thanks to the consortium & UL team! Let’s keep making medicines accessible to patients 🌱 #Teamit
🙌 Thank you to all who joined the #REMEDi4ALL General Assembly in Ljubljana.
Our community’s dedication & expertise drive progress in #DrugRepurposing – working together to bring safe & effective drugs to more patients.
➡️ Updates: https://remedi4all.org/
#DrugRepurposing
🇸🇮 We’re live from Ljubljana for the #REMEDi4ALL General Assembly!
After 3️⃣ years of collaboration, we’re looking back on our achievements & shaping the next steps to accelerate #PatientCentred medicines repurposing in Europe, & beyond.
➡️ More here: https://remedi4all.org #DrugRepurposing
Hope for new drugs headline
My latest: Medicines Reimagined – #Repurposing Drugs For New Indications via @forbes www.forbes.com/sites/judyst... #FDA #DrugRepurposing #MotorNeuronDisease #Malaria #RespiratoryPapilloma #HPV #Remedi4All #iDR25
⭐ 15 participants. 5 days. 1 challenge.
The #REMEDi4ALL Hackathon (6–10 Oct 2025) is a residential course where early-career researchers tackle the full #DrugRepurposing journey—guided by experts & patient advocates.
👉 Apply now: https://eatris.eu/events/remedi4all-hackathon-2025/
📣 Funders of repurposing: planning a call for #DrugRepurposing research? Our Practical Guide gives you everything you need to get started, including real-world examples from the #REMEDi4ALL Funders Network.
➡️ Download: https://loom.ly/njyk7j0 #ResearchFunding
📢 EMA has published new guidance to support not-for-profits & academics in repurposing authorised medicines. EATRIS leads #REMEDi4ALL – building Europe’s platform for #DrugRepurposing to boost access & drive innovation.
👉 Read more here: https://loom.ly/dIvh3BE
#REMEDi4ALL #EUfunded
What is drug repurposing—and why does it matter?
💡 Discover how repurposing existing medicines can speed up access to treatments & benefit healthcare systems.
Watch REMEDi4ALL’s explainer video & learn more:
🔗 www.youtube.com/watch?v=w69O...
#DrugRepurposing #REMEDi4ALL
Just one week left for the 2025 International #DrugRepurposing conference #iDR25!! As a partner of the #R4ALL project, #Chemotargets will be there represented by Nikola Panajotovikj.
👉 remedi4all.org/2025-interna...
#REMEDi4ALL #EATRIS #BeaconforRareDiseases #DrugRepurposing #HorizonEU
It's time to register for the international drug repurposing conference, #iDR25, where medicines are reimagined to unlock the potential of existing drugs for patient benefit!
@eatris.bsky.social @remedi4all.bsky.social
#REMEDi4ALL
remedi4all.org/2025-interna...
#RareDiseaseDay | 👉 Did you know there are over 7,000 rare diseases with known molecular basis, but only 500 have treatments?
💊 @remedi4all.bsky.social is advancing drug repurposing to develop new therapies, including for rare diseases.
🎥 Watch this video to find out more loom.ly/t1Kkzjs
#REMEDi4ALL
Introducing the #REMEDi4ALL Clinical Trials Webinar Series! 💻
Join Beacon for Rare Diseases, @eurordis.bsky.social & @ecrin.bsky.social for a 3-part series on clinical trials, starting Fri 21 Feb! 🔬
📅 Session 1: Intro to Clinical Trials + Q&A
🕚 11:00–12:30 CET
🎟️ Register now ➡️ loom.ly/I91LsfI
REMEDi4ALL is a #HorizonEU research initiative to drive forward the repurposing of medicines in Europe. The project, has the potential to reduce times & costs of drug development, making drug repurposing the new normal.
👉 More here: remedi4all.org
#REMEDi4ALL #DrugRepurposing
